Rachel Saunders-Pullman, MD, MPH, MS
- PROFESSOR | Neurology
Specialty:
NeurologyResearch Topic:
Parkinson's DiseaseDr. Rachel Saunders-Pullman is a movement disorders specialist at Mount Sinai Beth Israel/Mount Sinai, Bachmann-Strauss Chair, and Professor of Neurology at Icahn School of Medicine at Mount Sinai. She is a clinician, educator and clinical researcher whose clinical focus is in the care of patients with parkinsonism, dystonia, myoclonus and tremor. She treats Parkinson's disease and Parkinsonism, with focus on genetic Parkinson's; dystonia, including blepharospasm, cervical dystonia, limb dystonia; tremor; myoclonus; and ataxia, and genetic movement disorders.
Her research focus is the study of genetic and epidemiologic factors relating to Parkinson’s disease (PD) and dystonia with focus on the elucidation of new genes, and interaction between genes, and development of predictors and markers of PD and dystonia. These will be useful in understanding the underlying conditions, detecting disease earlier and tracking the progression of disease, with the goal of facilitating trials for PD and dystonia. Dr. Saunders-Pullman leads an NIH funded study evaluating oligogenic etiology of Parkinson Disease in Ashkenazi Jews, focused primarily on LRRK2 and GBA PD, and immune and lysosomal storage disorders. She is Co-Chair for the Movement Disorders Society Task Force on Genetic Testing in Parkinson Disease. She is the Program Director for the overall movement disorders fellowship for both Sinai programs.
Clinical Focus
- Parkinson's Disease
Education
MD, Columbia University College of Physicians & Surgeons
Internship, Internal Medicine, New York Presbyterian / Columbia University
Residency, Neurology, New York Presbyterian / Columbia University
Fellowship, Movement Disorders, New York Presbyterian / Columbia University
Fellowship, Epideminology, New York Presbyterian / Columbia University
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Saunders-Pullman did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.